Financhill
Back

ALX Oncology Holdings Vs. Neurocrine Biosciences Industry Stock Comparison

Sell
36

ALXO
ALX Oncology Holdings

Last Price:
1.52
Seasonality Move:
30.31%
Buy
57

NBIX
Neurocrine Biosciences

Last Price:
125.05
Seasonality Move:
16.93%
Sell
36
ALX Oncology Holdings (ALXO) is a Sell

Is ALX Oncology Holdings a Buy, Sell or Hold?

  • The current ALX Oncology Holdings [ALXO] share price is $1.53. The Score for ALXO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ALXO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Neurocrine Biosciences (NBIX) is a Buy

Is Neurocrine Biosciences a Buy, Sell or Hold?

  • The current Neurocrine Biosciences [NBIX] share price is $125.30. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALXO Stock Price Chart

What is ALX Oncology Holdings's stock price today?

  • The ALX Oncology Holdings share price today is $1.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight buying pressure.

NBIX Stock Price Chart

What is Neurocrine Biosciences's stock price today?

  • The Neurocrine Biosciences share price today is $125.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight buying pressure.

ALXO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 43.67 Sell
Chaikin Money Flow: 281250 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.44 - 1.64) Sell
Bollinger Bands (100): (1.29 - 5.61) Sell

NBIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 62.95 Buy
Chaikin Money Flow: 495738 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.03 - 120.55) Buy
Bollinger Bands (100): (117.75 - 145.33) Sell

ALXO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.46 Buy
20-day SMA: 1.5 Buy
50-day SMA: 1.82 Sell
200-day SMA: 8.58 Sell
8-day EMA: 1.49 Buy
20-day EMA: 1.55 Sell
50-day EMA: 2.15 Sell
200-day EMA: 6.23 Sell

NBIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 120.81 Buy
20-day SMA: 117.81 Buy
50-day SMA: 119.15 Buy
200-day SMA: 134.51 Sell
8-day EMA: 121.17 Buy
20-day EMA: 119.15 Buy
50-day EMA: 121.98 Buy
200-day EMA: 128.49 Sell

ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.

Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $1.11 per share.

ALX Oncology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurocrine Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):